DYADIC INTERNATIONAL INC. - COMMON STOCK

1.0700

09-May-25 16:45:00

15 minutes delayed

Stocks

-0.0100

-0.93%

Today's range

1.0601 - 1.1200

ISIN

N/A

Source

NASDAQ

Dyadic announces development of COVID-19 Vaccine in India

26 May 2021 08:30:01 By Nasdaq GlobeNewswire
Dyadic to Present at Upcoming Events

03 May 2021 08:30:00 By Nasdaq GlobeNewswire
Dyadic International Hosting a Fireside Chat on “The Potential of the Transformative Dyadic C1 Protein Technology in Helping Meet Global Health Challenges”

22 Apr 2021 08:30:01 By Nasdaq GlobeNewswire
UPDATE -- Dyadic Advancing Proprietary Owned COVID-19 vaccine candidate, DYAI-100, Towards Human Clinical Trial

29 Mar 2021 08:30:00 By Nasdaq GlobeNewswire
Dyadic and Medytox To Develop Vaccines Against COVID-19 Variants

23 Mar 2021 09:00:01 By Nasdaq GlobeNewswire
Dyadic and Medytox To Develop Vaccines Against COVID-19 Variants

22 Mar 2021 21:00:00 By Nasdaq GlobeNewswire
Dyadic and Medytox To Develop Vaccines Against COVID-19 Variants

22 Mar 2021 08:30:00 By Nasdaq GlobeNewswire
Dyadic Advancing Towards Human Clinical Trial of its SARS-CoV-2-S-RBD vaccine candidate, DYAI-100

18 Mar 2021 08:30:00 By Nasdaq GlobeNewswire
Dyadic Announces Scientific Achievements Reported During ZAPI Stakeholders Virtual Web Meeting

09 Mar 2021 08:30:00 By Nasdaq GlobeNewswire

<<
<
2
3
4
5
6
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.